These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10872096)

  • 21. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the absorption from some commercial enteric-release theophylline products.
    Upton RA; Powell JR; Guentert TW; Thiercelin JF; Sansom L; Coates PE; Riegelman S
    J Pharmacokinet Biopharm; 1980 Apr; 8(2):151-64. PubMed ID: 7431220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of curdlan to controlled drug delivery. I. The preparation and evaluation of theophylline-containing curdlan tablets.
    Kanke M; Koda K; Koda Y; Katayama H
    Pharm Res; 1992 Mar; 9(3):414-8. PubMed ID: 1614977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a sustained-release theophylline tablet in young asthmatics.
    Swigart SA; Kobayashi RH; Baldwin JN
    J Asthma; 1985; 22(4):195-202. PubMed ID: 4044473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
    Dey S; Mazumder B; Chattopadhyay S; Das MK; Sinha S; Ganguly S; De K; Mishra M
    Int J Biol Macromol; 2014 Apr; 65():346-56. PubMed ID: 24472506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
    Emeje MO; Kunle OO; Ofoefule SI
    Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of an aliphatic polyurethane as a microsphere matrix for sustained theophylline delivery.
    Subhaga CS; Ravi KG; Sunny MC; Jayakrishnan A
    J Microencapsul; 1995; 12(6):617-25. PubMed ID: 8558384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of a controlled-release theophylline tablet. Preliminary communication.
    Gai MN; Pezoa R; Corbeaux J; Arancibia A
    Farmaco; 1989 Nov; 44(11):1119-26. PubMed ID: 2701966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissolution studies of some sustained-release theophylline dosage forms.
    Simons KJ; Simons FE; Plett KD; Scerbo C
    J Pharm Sci; 1984 Jul; 73(7):939-42. PubMed ID: 6470957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of once-daily low-dose administration of sustained-release theophylline on airway inflammation and airway hyperresponsiveness in patients with asthma].
    Terao I
    Arerugi; 2002 Apr; 51(4):364-70. PubMed ID: 12014027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
    Bayomi MA; Al-Suwayeh SA; El-Helw AR
    Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group.
    Paggiaro PL; Giannini D; Di Franco A; Testi R
    Eur Respir J; 1996 Aug; 9(8):1689-95. PubMed ID: 8866596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum theophylline levels in young children receiving a sustained-release theophylline tablet.
    Howard ML; Baldwin JN; Kobayashi RH; Jensen BK
    J Asthma; 1984; 21(5):299-303. PubMed ID: 6501169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
    Makino S; Adachi M; Ohta K; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T; ;
    Allergol Int; 2006 Dec; 55(4):395-402. PubMed ID: 17130682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of pulsatile drug delivery system using novel polymer.
    Tekade AR; Gattani SG
    Pharm Dev Technol; 2009; 14(4):380-7. PubMed ID: 19235549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.